Advertisement

Spenderkonditionierung und Organentnahme

  • Ralf Hömme
  • Astrid Willker
Living reference work entry
Part of the Springer Reference Medizin book series (SRM)

Zusammenfassung

Die Transplantation menschlicher Organe ist eine etablierte und meist die einzige lebensrettende Therapie für Patienten im Endstadium eines Organversagens. Die Überlebensrate von Patient und Organen nach Transplantation wurde durch Fortschritte in der Organkonservierung, den operativen Techniken und der Immunsuppression gesteigert, ohne dass bis heute ein 100 %iger Erfolg realisierbar wäre.

Literatur

  1. 1.
    Angel LF, Levine DJ, Restrepo MI, Johnson S et al (2006) Impact of a lung transplantation donor-management protocol on lung donation and recipient outcomes. Am J Respir Crit Care Med 174:710–716CrossRefPubMedGoogle Scholar
  2. 2.
    Angelis M, Cooper JT, Freeman RB (2003) Impact of donor infections on outcome of orthotopic liver transplantation. Liver Transpl 9:451–462CrossRefPubMedGoogle Scholar
  3. 3.
    Bösebeck D, Fischer-Fröhlich CL et al (2011) Deutsche Stiftung Organtransplantation, „Leitfaden für die Organspende“. DSO, FrankfurtGoogle Scholar
  4. 4.
    Bugge JF (2009) Brain death and ist implications for management of the potential donor. Acta Anaesthesiol Scand 53:1239–1250CrossRefPubMedGoogle Scholar
  5. 5.
    Cooper DKC, Novitzky D, Wicomb WN (1989) The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. Ann R Coll Surg Engl 71:261–266PubMedPubMedCentralGoogle Scholar
  6. 6.
    Darby JM, Stein K, Grenvik A, Stuart SA (1989) Approach to management of the heartbeating „brain dead“ organ donor. JAMA 261:2222–2228CrossRefPubMedGoogle Scholar
  7. 7.
    Deutsche Stiftungc Organtransplantation (2013) Organspende und Transplantation in Deutschland – Jahresbericht 2013. http://www.dso.de/uploads/tx_dsodl/JB_2013_Web_05.pdf. Zugegriffen am 08.02.2015
  8. 8.
    Di Giantomasso D, Morimatsu H, May CN, Bellomo R (2002) Norepinephrine and vital organ blood flow. Intensive Care Med 28:1804–1809CrossRefPubMedGoogle Scholar
  9. 9.
    Eurotransplant International Foundation (2014). www.eurotransplant.org/cms/mediaobject.php?file=wl_donation_transplants_Germany1.pdf. Zugegriffen am 08.02.2015
  10. 10.
    Finfer S, Bohn D, Colpitts D et al (1996) Intensive care management of paediatric organ donors and its effect on posttransplant organ function. Intensive Care Med 22:1424–1432CrossRefPubMedGoogle Scholar
  11. 11.
    Freeman JW (1993) Donor selection and maintenance prior to multi organ retrieval. In: Vincent JL (Hrsg) Yearbook of intensive care and emergency medicine. Springer, Berlin/Heidelberg/New York/Tokio, S 671–683Google Scholar
  12. 12.
    Freeman RB, Giatras I, Falagas ME et al (1999) Outcome of transplantation of organs procured from bacteremic donors. Transplantation 68:1107–1111CrossRefPubMedGoogle Scholar
  13. 13.
    Goarin JP, Cohen S, Riou B et al (1996) The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg 83:41–47CrossRefPubMedGoogle Scholar
  14. 14.
    Gores PF, Viste A, Hesse UJ et al (1990) The influence of donor hyperglycaemia and other factors on long-term pancreatic allograft survival. Transplant Proc 22:437–438PubMedGoogle Scholar
  15. 15.
    Gramm HJ, Meinhold H, Bickel U et al (1992) Acute endocrine failure after brain death? Transplantation 54:851–857CrossRefPubMedGoogle Scholar
  16. 16.
    Gramm HJ, Zimmermann J, Meinhold H, Dennhardt R, Voigt K (1992) Hemodynamic responses to noxious stimuli in brain-dead organ donors. Intensive Care Med 18:493–495CrossRefPubMedGoogle Scholar
  17. 17.
    Howlett TA, Keogh AM, Perry L, Touzel R, Rees LH (1989) Anterior and posterior pituitary function in brain-stem-dead donors: a possible role for hormonal replacement therapy. Transplantation 47:828–834CrossRefPubMedGoogle Scholar
  18. 18.
    Jenkins DH, Reilly PM, Schwab CW (1999) Improving the approach to organ donation: a review. World J Surg 23:644–649CrossRefPubMedGoogle Scholar
  19. 19.
    Mauer D, Nehammer K, Bösebeck D, Wesslau C (2006) Die organprotektive Intensivtherapie bei postmortalen Organspendern. In: Mauer D, Gabel D (Hrsg) Intensivmedizin und Management bei Organspende und Transplantation. Steinkopff, DarmstadtCrossRefGoogle Scholar
  20. 20.
    Novitzky D, Wicomb WN, Cooper DKC et al (1984) Electrocardiographic, hemodynamic and endocrine changes occuring during experimental brain death in the Chacma baboon. J Heart Transplant 4:63–69Google Scholar
  21. 21.
    Nygaard CE, Townsend RN, Diamond DL (1990) Organ donor management and organ outcome: a 6-year review from a level I trauma center. J Trauma 30:728–732CrossRefPubMedGoogle Scholar
  22. 22.
    Pagano D, Bonser RS, Graham TR (1995) Optimal management of the heart-lung donor. Br J Hosp Med 53:522–525PubMedGoogle Scholar
  23. 23.
    Parry A, Higgins R, Wheeldon D, Bethune D, Wallwork J (1999) The contribution of donor management and modified cold blood lung perfusate to post-transplant lung function. J Heart Lung Transplant 18:121–126CrossRefPubMedGoogle Scholar
  24. 24.
    Perez-Blanco A, Caturla-Such J, Canovas-Robles J et al (2005) Efficiency of triiodothyronine treatment on organ donor hemodynamic management and adenine nucleotide concentration. Intensive Care Med 31:943–948CrossRefPubMedGoogle Scholar
  25. 25.
    Phongsamran PV (2004) Critical care pharmacy in donor management. Prog Transplant 14:105–113CrossRefPubMedGoogle Scholar
  26. 26.
    Powner DJ, Hernandez M (2005) A review of thyroid hormone administration during adult donor care. Prog Transplant 15:202–207CrossRefPubMedGoogle Scholar
  27. 27.
    Powner DJ, Hendrich A, Lagler RG, Ng RH, Madden RL (1990) Hormonal changes in brain dead patients. Crit Care Med 18:702–708CrossRefPubMedGoogle Scholar
  28. 28.
    Randell TT, Höckerstedt KAV (1992) Triiodothyronine treatment in brain-dead multiorgan donors: a controlled study. Transplantation 54:736–738CrossRefPubMedGoogle Scholar
  29. 29.
    S3-Leitlinie „Intravasale Volumentherapie beim Erwachsenen“ (2014). http://www.awmf.org/uploads/tx_szleitlinien/001-020l_S3_Intravasale_Volumentherapie_Erwachsenen_2014-09.pdf. Zugegriffen am 08.02.2015
  30. 30.
    Schnuelle P, Berger S, de Boer J, Persijn G, van der Woude FJ (2001) Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation 72:455–463CrossRefPubMedGoogle Scholar
  31. 31.
    Schnuelle P, Gottmann U, Hoeger S et al (2009) Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled clinical trial. JAMA 302:1067–1075CrossRefPubMedGoogle Scholar
  32. 32.
    Shemie SD, Ross H, Pagliarello J et al (2006) Organ donor management in Canada: recommendations of the forum on medical management to optimize donor organ potential. CMAJ 174(6):S13–S30CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Shivalkar B, Van Loon J, Wieland W, Tjandra-Maga TB (1993) Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation 87:230–239CrossRefPubMedGoogle Scholar
  34. 34.
    Smith M (2004) Physiologic changes during brain stem death – lessons for management of the organ donor. J Heart Lung Transplant 23:S217–S222CrossRefPubMedGoogle Scholar
  35. 35.
    Snell GI, Westall GP (2009) Donor selection and management. Curr Opin Organ Transplant 14:471–476CrossRefPubMedGoogle Scholar
  36. 36.
    Timmins AC, Hinds CJ (1991) Management of the multiple-organ donor. Curr Opin Anaesthesiol 4:287–292CrossRefGoogle Scholar
  37. 37.
    Van Bakel AB (1997) The cardiac transplant donor: identification, assessment, and management. Am J Med Sci 314:153–163PubMedGoogle Scholar
  38. 38.
    Van Remdonck D, Neyrinck A, Verleden GM et al (2009) Lung donor selection and management. Proc Am Thorac Soc 6:28–68CrossRefGoogle Scholar
  39. 39.
    Weiss S, Kotsch K, Francuski M et al (2007) Brain death activates donor organs and is associated with worse I/R injury after liver transplantation. Am J Transplant 7:1584–1593CrossRefPubMedGoogle Scholar
  40. 40.
    Wijdicks EFM (2001) The diagnosis of brain death. N Engl J Med 344:1215–1221CrossRefPubMedGoogle Scholar
  41. 41.
    Wood KE, Becker BN, McCarthney JG et al (2004) Care of the potential organ donor. N Engl J Med 351:2730–2739CrossRefPubMedGoogle Scholar
  42. 42.
    Young PJ, Matta BF (2000) Anaesthesia for organ donation in the brainstem dead – why bother? Anaesthesia 55:105–106CrossRefPubMedGoogle Scholar

Copyright information

© © Springer-Verlag GmbH Deutschland 2017

Authors and Affiliations

  1. 1.Niels-Stensen-Kliniken MarienhospitalOsnabrückDeutschland
  2. 2.Klinikum Augsburg, Klinik für Anästhesiologie und operative IntensivmedizinAugsburgDeutschland

Personalised recommendations